case_images: PMC10225497_01
case_images: (A) Changes in AFP levels during CAR T-cell therapy. (B) Changes in lymphocyte numbers during CAR T-cell therapy.
case_images: fimmu-14-1180001-g001.jpg
case_images: PMC10225497_01_fimmu-14-1180001-g001.jpg
case_images: f1
case_images: The variations in AFP levels are shown in  Figure 1A . T-cell therapy is shown in  Figure 1B . The amount of re-infused T cells in each cycle was 6.0x106 CAR+ cell number/kg body weight, and the total amount was 522x106/80 mL.
case_images: Changes in abdominal ECT after the initial CAR T-cell therapy on April 19, 2018 (A), July 6, 2018 (B), January 25, 2019 (C), May 10, 2019 (D), respectively.
case_images: fimmu-14-1180001-g002.jpg
case_images: PMC10225497_01_fimmu-14-1180001-g002.jpg
case_images: f2
case_images: (A) Changes between the prior-treatment and post-treatment MRI pictures of the abdomen. (B) CT scan of the chest and abdomen one year after liver transplantation.
case_images: fimmu-14-1180001-g003.jpg
case_images: PMC10225497_01_fimmu-14-1180001-g003.jpg
case_images: f3
case_images: The follow-up rechecks of the AFP level and the chest and abdominal CT ( Figure 3B ) were conducted after one year of the transplantation.
case_images: The treatment schedule for this patient.
case_images: fimmu-14-1180001-g004.jpg
case_images: PMC10225497_01_fimmu-14-1180001-g004.jpg
case_images: f4